Estimating Kidney Failure Risk Using Electronic Medical Records

被引:10
作者
Naranjo, Felipe S. [1 ,2 ]
Sang, Yingying [3 ,4 ,5 ]
Ballew, Shoshana H. [3 ,4 ]
Stempniewicz, Nikita [6 ]
Dunning, Stephan C. [5 ]
Levey, Andrew S. [7 ]
Coresh, Josef [3 ,4 ]
Grams, Morgan E. [2 ,3 ]
机构
[1] Univ Nebraska Med Ctr, Dept Med, Div Nephrol, Omaha, NE USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, 1830 East Monument St,4th Floor,Suite 416, Baltimore, MD 21287 USA
[3] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA
[5] OptumLabs, Cambridge, MA USA
[6] Amer Med Grp Assoc, Alexandria, VA USA
[7] Tufts Med Ctr, Div Nephrol, Boston, MA 02111 USA
来源
KIDNEY360 | 2021年 / 2卷 / 03期
关键词
chronic kidney disease; albuminuria; electronic health records; kidney failure; GLOMERULAR-FILTRATION-RATE; DISEASE; ALBUMINURIA; PROTEINURIA; ESRD; CKD; HYPERTENSION; ASSOCIATION; PROGRESSION; PREDICTION;
D O I
10.34067/KID.0005592020
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background The four-variable kidney failure risk equation (KFRE) is a well-validated tool for patients with GFR < 60 ml/min per 1.73 m(2) and incorporates age, sex, GFR, and urine albumin-creatinine ratio (ACR) to forecast individual risk of kidney failure. Implementing the KFRE in electronic medical records is challenging, however, due to low ACR testing in clinical practice. The aim of this study was to determine, when ACR is missing, whether to impute ACR from protein-to-creatinine ratio (PCR) or dipstick protein for use in the four-variable KFRE, or to use the three-variable KFRE, which does not require ACR. Methods Using electronic health records from OptumLabs Data Warehouse, patients with eGFR < 60 ml/min per 1.73 m(2) were categorized on the basis of the availability of ACR testing within the previous 3 years. For patients missing ACR, we extracted urine PCR and dipstick protein results, comparing the discrimination of the three-variable KFRE (age, sex, GFR) with the four-variable KFRE estimated using imputed ACR from PCR and dipstick protein levels. Results There were 976,299 patients in 39 health care organizations; 59% were women, the mean age was 72 years, and mean eGFR was 47 ml/min per 1.73 m(2). The proportion with ACR testing was 19% within the previous 3 years. An additional 2% had an available PCR and 36% had a dipstick protein; the remaining 43% had no form of albuminuria testing. The four-variable KFRE had significantly better discrimination than the three-variable KFRE among patients with ACR testing, PCR testing, and urine dipstick protein levels, even with imputed ACR for the latter two groups. Calibration of the four-variable KFRE was acceptable in each group, but the three-variable equation showed systematic bias in the groups that lacked ACR or PCR testing. Conclusions Implementation of the KFRE in electronic medical records should incorporate ACR, even if only imputed from PCR or urine dipstick protein levels.
引用
收藏
页码:415 / 424
页数:10
相关论文
共 33 条
  • [1] Predictors of Initiation for Predialysis Arteriovenous Fistula
    Al-Balas, Alian
    Lee, Timmy
    Young, Carlton J.
    Barker-Finkel, Jill
    Allon, Michael
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (10): : 1802 - 1808
  • [2] [Anonymous], 2013, KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease No
  • [3] Quality of Chronic Kidney Disease Management in Canadian Primary Care
    Bello, Aminu K.
    Ronksley, Paul E.
    Tangri, Navdeep
    Kurzawa, Julia
    Osman, Mohamed A.
    Singer, Alexander
    Grill, Allan K.
    Nitsch, Dorothea
    Queenan, John A.
    Wick, James
    Lindeman, Cliff
    Soos, Boglarka
    Tuot, Delphine S.
    Shojai, Soroush
    Brimble, K. Scott
    Mangin, Dee
    Drummond, Neil
    [J]. JAMA NETWORK OPEN, 2019, 2 (09)
  • [4] Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
    Carrero, Juan Jesus
    Grams, Morgan E.
    Sang, Yingying
    Arnlov, Johan
    Gasparini, Alessandro
    Matsushita, Kunihiro
    Qureshi, Abdul R.
    Evans, Marie
    Barany, Peter
    Lindholm, Bengt
    Ballew, Shoshana H.
    Levey, Andrew S.
    Gansevoort, Ron T.
    Elinder, Carl G.
    Coresh, Josef
    [J]. KIDNEY INTERNATIONAL, 2017, 91 (01) : 244 - 251
  • [5] Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
    Coresh, Josef
    Heerspink, Hiddoj L.
    Sang, Yingying
    Matsushita, Kunihiro
    Arnlov, Johan
    Astor, Brad C.
    Black, Corti
    Brunskill, Nigel J.
    Carrero, Juan-Jesus
    Feldman, Harold, I
    Fox, Caroline S.
    Inker, Lesley A.
    Ishani, Areef
    Ito, Sadayoshi
    Jassal, Simerjot
    Konta, Tsuneo
    Polkinghorne, Kevan
    Romundstad, Solfrid
    Solbu, Marit D.
    Stempniewicz, Nikita
    Stengel, Benedicte
    Tonelli, Marcello
    Umesawa, Mitsumasa
    Waikar, Sushruts
    Wen, Chi-Pang
    Wetzels, Jack F. M.
    Woodward, Mark
    Grams, Morgan E.
    Kovesdy, Csaba P.
    Levey, Andrew S.
    Gansevoort, Ron T.
    Hallan, Stein
    Shalev, Varda
    Chalmers, John
    Arima, Hisatomi
    Perkovic, Vlado
    Levin, Adeera
    Djurdjev, Ognjenka
    Tang, Mila
    Nally, Joseph
    Navaneethan, Sankar
    Schold, Jesse
    Weldegiorgis, Misghina
    Herrington, William
    Smith, Margaret
    Feldman, Harold
    Hsu, Yenchih
    Fox, Caroline
    Hwang, Shih-Jen
    Chang, Alex R.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (02) : 115 - 127
  • [6] Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results
    de Lusignana, Simon
    Gallagher, Hugh
    Jones, Simon
    Chan, Tom
    van Vlymen, Jeremy
    Tahir, Aumran
    Thomas, Nicola
    Jain, Neerja
    Dmitrieva, Olga
    Rafi, Imran
    McGovern, Andrew
    Harris, Kevin
    [J]. KIDNEY INTERNATIONAL, 2013, 84 (03) : 609 - 620
  • [7] Should albuminuria be a therapeutic target in patients with hypertension and diabetes?
    de Zeeuw, D
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (11) : 11S - 15S
  • [8] Strategies for planning the optimal dialysis access for an individual patient
    Drew, David A.
    Lok, Charmaine E.
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (03) : 314 - 320
  • [9] Evolving importance of kidney disease: from subspecialty to global health burden
    Eckardt, Kai-Uwe
    Coresh, Josef
    Devuyst, Olivier
    Johnson, Richard J.
    Koettgen, Anna
    Levey, Andrew S.
    Levin, Adeera
    [J]. LANCET, 2013, 382 (9887) : 158 - 169
  • [10] Renal Association Clinical Practice Guideline on Vascular Access for Haemodialysis
    Fluck, Richard
    Kumwenda, Mick
    [J]. NEPHRON CLINICAL PRACTICE, 2011, 118 : C225 - C240